We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Calcineurin Inhibitor Avoidance With Thymoglobulin and Sirolimus in Kidney Transplantation

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00305396
Recruitment Status : Completed
First Posted : March 21, 2006
Last Update Posted : March 21, 2006
Genzyme, a Sanofi Company
Information provided by:
Vanderbilt University

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Primary Completion Date : No date given
  Estimated Study Completion Date : March 2005